Skip to content
Screener

Current ratio at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-1.3×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
21×+5.9×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
+0.6×
Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
15.7×-7.0×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
2.9×-0.2×
Biogen logo
BiogenBIIB
1.9×-0.6×

Other financials

Income statement

See full
Revenue--100%
Operating income-$96.9M-27.4%
Net income-$83.7M-17.7%
EPS (diluted)-$2.87+13.3%

Balance sheet

See full
Cash & equivalents$474.8M+201%
Total debt$1.1M+44.0%
Total equity$1.3B+232%
Total assets$1.4B+207%

Cash flow

See full
Operating cash flow-$77.5M-41.8%
CapEx$245.0K+338%
Free cash flow-$77.8M-42.1%

Valuation

See full
Market cap$8.9B+770%
Enterprise value$8.43B+873%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-38.9%-10.3pp
Debt / equity0.0×

Where this comes from

Calculated from Praxis Precision Medicines, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Praxis Precision Medicines, Inc.’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 8:32 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001689548-26-000083

FAQ

What is Praxis Precision Medicines, Inc.'s current ratio?
Praxis Precision Medicines, Inc. (PRAX) reported current ratio of 15.7× in Q2 2026.
How has Praxis Precision Medicines, Inc.'s current ratio changed year-over-year?
Praxis Precision Medicines, Inc.'s current ratio increased by 149.5% year-over-year, from 6.3× to 15.7×.
What is the long-term trend for Praxis Precision Medicines, Inc.'s current ratio?
Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s current ratio has grown at a -11.9% compound annual growth rate (CAGR), from 19.2× to 10.2×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about Praxis Precision Medicines, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude